Study of SIROPSEDAL for Recent-Onset Cough
Part of Infections, Lungs & breathing clinical trials.
This study watches how well SIROPSEDAL (a cough medicine) works for people with a cough that started recently. You'll be treated with this medicine as your doctor normally would, and the study team will check in with you after a week to see how you're doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 1 year or older
- Cough started less than 10 days ago and is significantly bothersome (score above 40/100)
- Your doctor has already decided to prescribe SIROPSEDAL for you (not because of this study)
- You don't need to be hospitalized right now
- You can attend a visit or video call 7 days later (plus or minus 1 day)
- You have health insurance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how a nasal spray called Rhinosedal helps people who suddenly get stuffy noses from colds, allergies, or sinus inflammation. Researchers want to see if it relieves your symptoms quickly.
This trial tests treatments for a recent dry or productive cough caused by a common viral infection like a cold or sore throat. It aims to find options that are safe and effective for adults who are otherwise healthy.
This trial tests if a new cough syrup (Rengalin) helps children ages 6 months to 3 years with a dry cough from a viral cold. It aims to reduce cough severity and improve comfort for your child.
This 24-week study tests whether a new medicine called BLU-5937 can help adults whose chronic cough hasn't improved with standard treatments. Chronic cough that lasts a year or longer can seriously affect quality of life, and this trial explores whether this drug might provide relief.
This study tests a combination medicine containing pain reliever, caffeine, and allergy medication to help ease nasal congestion and other cold or flu symptoms. You'd take the medicine for a short period and report how well it works.
This trial tests an oral medication (VPV) to see if it can safely treat rhinovirus (a common cold virus) in people with COPD. The goal is to help you recover faster and prevent serious COPD flare-ups.
Hear when a new Upper Respiratory Tract Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.